Antitumor Effects of a Soluble Insulin-Like Growth Factor I Receptor in Human Ovarian Cancer Cells: Advantage of Recombinant Protein Administration in Vivo

Cancer Research

Volumn 63, Issue 22, 2003, Pages 7834-7839

  Hongo, Atsushi ^a   Kuramoto, Hiroyuki ^a   Nakamura, Yojiro ^a   Hasegawa, Kosei ^a   Nakamura, Keiichiro ^a   Kodama, Junichi ^a   Hiramatsu, Yuji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; CANCER CELL; CARCINOGENICITY; CELL LYSATE; COCULTURE; CONTROLLED STUDY; DRUG EFFECT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; OVARY CARCINOMA; OVARY CELL; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; FEMALE; HUMANS; MICE; MICE, NUDE; OVARIAN NEOPLASMS; RECEPTOR, IGF TYPE 1; RECOMBINANT PROTEINS; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0344844466     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Baserga, R., Hongo, A., Rubini, M., Prisco, M., and Valentinis, B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta, 1332: 105-126, 1997.
2. Kaleko, M., Rutter, W. G., and Mille, A. D. Overexpression of the human insulin-like growth factor I receptor promotes ligand-independent neoplastic transformation. Mol. Cell. Biol., 10: 464-473, 1990.
3. Harrington, E. A., Bennett, M. R., Fandini, A., and Evan, G. I. c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13: 3286-3295, 1994.
4. Jung, Y. K., Miura, M., and Yuan, J. Suppression of interleukin-1β converting enzyme-mediated cell death by insulin-growth factor. J. Biol. Chem., 271: 5112-5117, 1996.
5. Prisco, M., Hongo, A., Rizzo, M. G., Sacchi, A., and Baserga, R. The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol. Cell. Biol., 17: 1084-1092, 1997.
6. Nakamura, S., Watanabe, H., Miura, M., and Sasaki, T. Effect of the insulin-like growth factor I receptor on ionizing radiation-induced cell death in mouse embryo fibroblasts. Exp. Cell Res., 235: 287-294, 1997.
7. Wu, Y., Tewai, M., Cui, S., and Rubin, R. Activation of the insulin-like growth factor I receptor inhibits tumor necrosis factor-induced cell death. J. Cell. Physiol., 168: 499-509, 1996.
8. McCubrey, J. A., Stillman, L. S., Mayhew, M. W., Algate, P. A., Dellow, R. A., and Kaleko, M. Growth promoting effects of insulin-like growth factor I (IGF-I) on hematopoietic cells. Overexpression of introduced IGF-I receptor abrogates interleukin-3 dependency of murine factor dependent cells by ligand-dependent mechanism. Blood, 78: 921-929, 1991.
9. O'Connor, R., Kauffmann-Zeh, A., Liu, Y., Lehar, S., Evan, G. I., Baserga, R., and Blättler, W. A. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol. Cell. Biol., 17: 427-435, 1997.
10. Dews, M., Nishimoto, I., and Baserga, R. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins. Recept. Signal. Transduct., 7: 231-240, 1997.
11. D'Ambrosio. C., Valentinis, B., Prisco, M., Reiss, K., Rubini, M., and Baserga, R. Protective effect of the insulin-like growth factor I receptor on apoptosis induced by okadaic acid. Cancer Res., 57: 3264-3271. 1999.
12. Kulik, G., Klippel, A., and Weber, M. J. Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol., 17: 1595-1606, 1997.
13. Sell, C., Baserga, R., and Rubin, R. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res., 55: 303-306, 1995.
14. Dunn, S. E., Hardman, R. A., Kari, F. W., and Barrett, J. C. Insulin-like growth factor I (IGF-I) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res., 57: 2687-2693, 1997.
15. Kulik, G., and Weber, M. J. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Mol. Cell. Biol., 18: 6711-6718, 1998.
16. Peruzzi, F., Prisco, M., Dews, M., Salomoni, P., Grassilli, E., Romano, G., Calabretta, B., and Baserga, R. Multiple signaling pathways of the insulin-like growth factor I receptor in protection from apoptosis. Mol. Cell. Biol., 19: 7203-7215, 1999.
17. Nanarro, M., and Baserga, R. Limited redundancy of survival signals from the type I insulin-like growth factor receptor. Endocrinology, 142: 1073-1081, 2001.
18. Peruzzi, F., Prisco, M., Morrione, A., Valentinis, B., and Baserga, R. Anti-apoptotic signaling of the insulin-like growth factor I receptor through mitochondrial translocation of c-Raf and Nedd4. J. Biol. Chem., 276: 25990-25996, 2001.
19. Nakamura, K., Hongo, A., Kodama, J., Miyagi, Y., Yoshinouchi, M., and Kudo, T. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines. Cancer Res., 60: 760-765, 2000.
20. Burfeind, P., Chernicky, C. L., Rininsland, F., Ilan, J., and Ilan. J. Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc. Natl. Acad. Sci. USA, 93: 7263-7268, 1996.
21. Lee, C. T., Wu, S., Gabrivolich, D., Chen, H., Nadaf-Rahrov, S., Ciernick, I. F., and Carbone, D. P. Antitumor effect of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines. Cancer Res., 56: 3038-3041, 1996.
22. Liu, X., Turbyville, T., Fritz, A., and Whitesell, L. Inhibition of insulin-like growth factor I receptor expression in neuroblastoma cells induces the regression of established tumors in mice. Cancer Res., 58: 5432-5438, 1998.
23. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H., Kajstura, J., Rubin, R., Zoltick, P., and Baserga, R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55: 2463-2469, 1995.
24. Resnicoff, M., Burgaud, J. L., Rotman, H. L., Abraham, D., and Baserga, R. Correlation between apoptosis, tumorigenesis and levels of insulin-like growth factor I receptor. Cancer Res., 55: 3739-3741, 1995.
25. Trojan, J., Johnson, T. R., Rudin, S. D., Ilan, M., Tykocinski, M., and Ilan, J. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science (Wash. DC), 259: 94-97, 1993.
26. Rininsland, F., Johnson, T. R., Chernicky, C. L., Schulze, E., Burfeind, B., Ilan, J., and Ilan, J. Suppression of insulin-like growth factor I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells. Proc. Natl. Acad. Sci. USA, 94: 5854-5859, 1997.
27. Hongo, A., Yumet, G., Resnicoff, M., Romano, G., O'Connor, R., and Baserga, R. Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor. Cancer Res., 58: 2477-2484, 1998.
28. Liu, Y., Lehar, S., Corvi, C., Payne, G., Chittenden, T., and O'Connor, R. Expression of the IGF-I receptor C terminus as a myristylated protein leads to induction of apoptosis in tumor cells. Cancer Res., 58: 570-576, 1998.
29. Burgaud, J. L., Resnicoff, M., and Baserga, R. Mutant IGF-I receptors as dominant negatives for growth and transformation. Biochem. Biophys. Res. Commun., 214: 475-481, 1995.
30. Prager, D., Li, H. L., Asa, S., and Melmed, S. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor receptor mutant. Proc. Natl. Acad. Sci. USA, 91: 2181-2185, 1994.
31. D'Ambrosio, C., Ferber, A., Resnicoff, M., and Baserga, R. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res., 56: 4013-4020, 1996.
32. Dunn, S. E., Ehrlich, M., Sharp, N. J. H., Reiss, K., Solomon, G., Hawkins, R., Baserga, R., and Barrett, J. C. A dominant negative mutant of the insulin-like growth factor I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res., 58: 3353-3361, 1998.
33. Reiss, K., D'Ambrosio, C., Tu, X., Tu, C., and Baserga, R. Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect. Clin. Cancer Res., 4: 2647-2655, 1998.
34. McCarthy, N. J., Whyte, M. K. B., Gilbert, C. S., and Evan, G. I. Inhibition of Ced3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell. Biol., 136: 215-227, 1997.
35. Whittaker, J., Groth, A. V., Mynarcik, D. C., Pluzek, L., Gadsboll, V. L., and Whittaker, L. J. Alanine scanning mutagenesis of a type I insulin-like growth factor receptor ligand binding site. J. Biol. Chem., 276: 43980-43986, 2001.
36. Reiss, K., Tu, X., Romano, G., Peruzzi, F., Wang, J. Y., and Baserga, R. Intracellular association of a mutant insulin-like growth factor receptor with endogenous receptors. Clin. Cancer Res., 7: 2134-2144, 2001.
37. Romano, G., Reiss, K., Tu, X., Peruzzi, F., Belletti, B., Wang, J. Y., Zanocco-Marani, T., and Baserga, R. Efficient in vitro and in vivo gene regulation of a retrovirally delivered pro-apoptotic factor under the control of the Drosophila HSP70 promoter. Gene Ther., 8: 600-607, 2001.